4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001562180-19-002477
Chief Financial Officer sold 35,000 shares at $203.08 ($7,107,681)
- Chief Financial Officer acquired 35,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hippel James Chief Financial Officer | 2019-05-01 | Option exercise | +35,000 | $86.25 | $3,018,750 | 39,382 | D |
| Hippel James Chief Financial Officer | 2019-05-01 | Sale | −35,000 | $203.08 | $7,107,681 | 4,382 | D |
| Derivatives | |||||||
| Hippel James Chief Financial Officer | 2019-05-01 | Option exercise · Stock Options (Right to buy) | +10,000 | 0 | D | ||
| Hippel James Chief Financial Officer | 2019-05-01 | Option exercise · Stock Options (Right to buy) | +25,000 | 0 | D | ||
| Open-market sales · 35,000 sh · avg $203.08 · $7,107,681 | |||||||
Loading xslF345X03/primarydocument.xml…